Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats

Chinese Medical Journal

Volumn 120, Issue 21, 2007, Pages 1902-1907

  Chen, Hong Juan ^a   Yao, Lei ^a   Chen, Tu Gang ^a   Yu, Min ^a   Wang, Li Hong ^a   Chen, Jun Zhu ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Atorvastatin; Connexin43; Hypertrophy, left ventricular; Rats, spontaneously hypertensive

Indexed keywords

ATORVASTATIN; BRAIN NATRIURETIC PEPTIDE; CONNEXIN 43; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GAP JUNCTION; GENE OVEREXPRESSION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID BLOOD LEVEL; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; WISTAR KYOTO RAT;

EID: 36148962351     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200711010-00010     Document Type: Article

References (20)

1. Jongsma HJ, Wilders R. Gap junctions in cardiovascular disease. Circ Res 2000; 86: 1193-1197.
2. Figueroa XF, Isakson BE, Duling BR. Vascular gap junctions in hypertension. Hypertension 2006; 48: 804-811.
3. Haefliger JA, Meda R Connexins, renin and hypertension. Med Sci (Paris) 2006; 22: 826-827.
4. Haefliger JA, Krattinger N, Martin D, Pedrazzini T, Capponi A, Doring B, et al. Connexin43-dependent mechanism modulates rennin secretion and hypertension. J Clin Invest 2006; 116: 405-413.
5. Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol Sci 1998; 19: 229-241.
6. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 2001; 51: 217-229.
7. Sowers JR. Effects of statins on the vasculature: implications for aggressive lipid management in the cardiovascular metabolic syndrome. Am J Cardiol 2003; 91(4A): 1411-22B.
8. Takemoto M, Node K, Nakagami H, Liao Y, Grimp M, Takemoto Y, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001; 108: 1429-4437.
9. Yeh HI, Lee PY, Su CH, Tian TY, Ko YS, Tsai CH. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment. Am J Hypertens 2006; 19: 129-135.
10. Jiang YG, Jiang R, Jin J, Wang HP, Chen JH. Changes of junction in penile cavernous smooth muscle cells of hypertensive rats. Nat J Androl 2006; 12: 1010-1013.
11. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions, in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993; 88: 864-875.
12. Uzzaman M, Honji H, Takagishi Y, Emad L, Magee AI, Severs NJ, et al. Remodelling of gap junctional coupling of rats with monocrotaline-induced pulmonary hypertension. Circ Res 2000; 86: 871-878.
13. Kostin S, Rieger M, Dammer S, Hein S, Richter M, Klovekorn WP, et al. Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol Cell Biochem 2003; 242: 135-144.
14. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlborn U, et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001; 38: 883-891.
15. Severs NJ. Gap junction-mediated intercellular signaling in health and disease. Novartis Foundation symposium. London: Novartis Foundation; 1999: 188-211.
16. Shyu KG, Chen CC, Wang BW, Kuan P, Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytess. J Mol Cell Cardiol, 2001; 33: 691-698.
17. Werner N, Nickening G, Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors, Basic Res Cardiol 2002; 97: 105-116.
18. Hasegawa H, Yamamoto R, Takano H, Mizukami M, Asakawa M, Nagai T, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats. J Mol Cell Cardiol 2003; 35: 953-960.
19. Wang LH, Chen JZ, Sun YL, Zhang FR, Zhu JH, Hu SJ, et al. Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Int J Cardiol 2005; 100: 467-475.
20. Wong CW, Burger F, Pelli G, Mach F, Kwak BR. Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice. Cell Commun Adhes 2003; 10: 395-400.